ARCHIVES

B-14 Trial: No Advantage To 10 Years Of Tamoxifen

This article is from The Cancer Letter archive.

Vol. 24 No. 5 | May 25, 2001

Download PDF Visit The Full Archive

Related Articles

Capitated Oncology Becomes Marketplace Reality Wit Plan By Companies

January 14, 1994

Study Finds Trial Results Reliable At Three Years

July 29, 2005

Patient Accrual Up More Than 20% This Year Despite Lack Of Significant New Money For Group

November 18, 1988

Clinical Trials Streamlining Moves Forward; NCI Commits To Full Funding For Groups

October 9, 1998

Avastin Combination Approved For Metastatic Colorectal Cancer

February 22, 2013

OMB Budget Revision Would Cut Centers $20 Million, Slash Clinical Education, Training, Contracts Funds

April 22, 1983